Literature DB >> 2755080

Interphase cytogenetics in paraffin embedded sections from human testicular germ cell tumor xenografts and in corresponding cultured cells.

P Emmerich1, A Jauch, M C Hofmann, T Cremer, H Walt.   

Abstract

A protocol was developed that allows determination of chromosome aberrations in interphase nuclei from paraffin embedded human tissues. As a model system tissue sections from xenografts derived from three testicular germ cell tumors (two teratocarcinoma and one embryonal carcinoma), as well as sections from normal intestine and testicular tissues, were hybridized with a biotin-labeled DNA probe specific for 1q12. For comparison, isolated nuclei in suspension and metaphase spreads from in vitro cell lines derived from the respective xenografts were assayed. Our results show that interphase tumor cells with aberrant numbers of chromosome 1 can be reliably detected both in vitro and in vivo. Subclones with two and three labeled chromosomes, respectively, could be defined and quantitatively evaluated. Present and future possibilities to pinpoint specific chromosome aberrations directly in cells present in body fluids or in tumor tissues are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2755080

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  Biopsy specimen identification by detection of sex chromosomes: application of in situ hybridisation.

Authors:  R E Kibbelaar; C F Leenheers-Binnendijk; P J Spaander; P M Kluin
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

2.  Feasibility of in situ hybridisation with chromosome specific DNA probes on paraffin wax embedded tissue.

Authors:  E P Arnoldus; E J Dreef; I A Noordermeer; M M Verheggen; R F Thierry; A C Peters; C J Cornelisse; M Van der Ploeg; A K Raap
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

3.  Chromosomal in situ suppression hybridization of human gonosomes and autosomes and its use in clinical cytogenetics.

Authors:  A Jauch; C Daumer; P Lichter; J Murken; T Schroeder-Kurth; T Cremer
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

4.  Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity.

Authors:  S Y Kim; J S Lee; J Y Ro; M L Gay; W K Hong; W N Hittelman
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

Review 5.  Interphase cytogenetics and its role in molecular diagnostics of solid tumors.

Authors:  T Ried
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

6.  Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization.

Authors:  A Giwercman; A H Hopman; F C Ramaekers; N E Skakkebaek
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

7.  Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.

Authors:  T Chen; K Dhingra; A Sahin; N Sneige; G Hortobagyi; C M Aldaz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Correlation of microscopic phenotype with genotype in a formalin-fixed, paraffin-embedded testicular germ cell tumor with universal DNA amplification, comparative genomic hybridization, and interphase cytogenetics.

Authors:  M R Speicher; A Jauch; H Walt; S du Manoir; T Ried; W Jochum; T Sulser; T Cremer
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

Review 9.  Spatial analysis of intranuclear human repetitive DNA regions by in situ hybridization and digital fluorescence microscopy.

Authors:  H van Dekken; R Hulspas
Journal:  Histochem J       Date:  1993-03

10.  Confirmation of the copy number of chromosome 1 in interphase nuclei from paraffin sections of breast tumours by fluorescence in situ hybridization.

Authors:  M L Loupart; R Walker; W Brammar; J Varley
Journal:  Chromosome Res       Date:  1995-11       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.